PredniSONE Tablets — Class II drug recall D-149-2013
Terminated recall by West-ward Pharmaceutical Corp., reported 2013-02-13, distributed nationwide. Presence of Foreign Substance: Tablets are being recalled due to gray defects identified in the tablets.
| Recall number | D-149-2013 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | West-ward Pharmaceutical Corp., Eatontown, NJ, United States |
| Recall initiated | 2012-12-05 |
| Classified | 2013-02-05 |
| Reported by FDA | 2013-02-13 |
| Terminated | 2015-03-18 |
| Distributed | Nationwide (US) |
| Quantity | 128,319 bottles |
| NDC | 00143-1473-01, 00143-1473-10 |
| Lot numbers | 10/15, 11/15, 12/15, 69403A, 69403B, 69404A, 69405A, 69515A, 69702A, 69702B, 69703A, 69767A, 69767B |
Product
PredniSONE Tablets, USP, 10 mg, packaged in a) 100-count tablets per bottle (NDC 0143-1473-01), b) 1000-count tablets per bottle (NDC 0143-1473-10), Rx only, Manufactured by: West-ward Pharmaceutical Corp., Eatowntown, NJ 07724.
Reason for recall
Presence of Foreign Substance: Tablets are being recalled due to gray defects identified in the tablets.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-149-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.